Fundraising Fox心擎医疗
1 known investors
Find your way into 心擎医疗
Sign up to see every warm intro you have to 心擎医疗
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 心擎医疗 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MagAssist develops a multi-organ support platform for cardiac and critical care, starting from heart failure treatment. Its pipeline includes an extracorporeal fully magnetically-levitated artificial heart, a minimally invasive interventional artificial heart, a next-generation ECMO (extracorporeal membrane oxygenation) system, and a warm-blood organ transport platform.
Investors · 1
Frequently asked questions
- What does 心擎医疗 do?
- MagAssist develops a multi-organ support platform for cardiac and critical care, starting from heart failure treatment. Its pipeline includes an extracorporeal fully magnetically-levitated artificial heart, a minimally invasive interventional artificial heart, a next-generation ECMO (extracorporeal membrane oxygenation) system, and a warm-blood organ transport platform.
- Who are 心擎医疗's investors?
- 心擎医疗's investors include Med-Fine Capital.